Live Breaking News & Updates on Initiates Rolling Submission

Stay updated with breaking news from Initiates rolling submission. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

VALNEVA: Valneva Reports Full Year 2022 Results and Provides Corporate Updates

Total revenues of €361.3 million in 2022 compared to €348.1 million in 2021 Driven by product sales of €114.8 million (82.3% increase compared to 2021), including €85.2 million of travel vaccine sales ....

New Zealand , United Kingdom , United Arab Emirates , United States , Kingdom Of Bahrain , Deerfield Orbimed , Instituto Butantan , Joshua Drumm , Vivalis Intercell , Tropical Disease Priority Review Voucher Program , Vaccines Announce European Partnership For Marketing , Global Communications , Drug Administration , European Commission For Valneva Inactivated , Pan American Health Organization , European Medicines Agency , Us Department Of Defense , European Union Member States , European Commission , European Union , Deerfield Management Company Orbimed , Coalition For Epidemic Preparedness Innovations , Euronext Paris , Chief Financial Officer , Biologics License Application , Prescription Drug User Fee Act ,

Janssen: New Data from CARTITUDE-1 Study Show Continued Deep and Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) in Treatment of Heavily Pre-treated Patients with Multiple Myeloma

Data presented at ASH 2021 congress show 83 percent of patients achieved a stringent complete response at median follow-up of 22 months1 92 percent of evaluable patients achieved minimal residual ....

United States , Ciltacabtagene Autoleucel , Noah Reymond , Edmond Chan Mbch , Thomas Martin , Sen Zhuang , Jessica Moore , Myeloma Program , Janssen Biotech Inc , American Society Of Clinical Oncology , American Society Of Hematology Annual Meeting , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , American Society Of Hematology , Clinical Research , American Cancer Society , None Of The Janssen Pharmaceutical Companies , Bone Marrow Transplantation Program , Drug Administration , International Staging System , Exchange Commission , Companies Of Johnson , European Medicines Agency , European Medicines Agency Seeking Approval , Hematopoietic Malignancies Program ,

Janssen Reports New Data for BCMA CAR-T, Cilta-Cel, Showing Deep and Durable Responses in Patients with Relapsed or Refractory Multiple Myeloma

Eighteen-month follow-up data from pivotal CARTITUDE-1 study, including progression-free-survival data, to be presented at ASCO and EHA Annual Meetings Findings from the Phase 2 CARTITUDE-2 study ....

United States , Ciltacabtagene Autoleucel , Noah Reymond , Jennifer Mcintyre , Saadz Usmani , Christopher Delorefice , Sen Zhuang , Edmond Chan , Hematology Am Soc Hematol Educ Program , National Cancer Institute , Janssen Biotech Inc , American Society Of Clinical Oncology , American Society Of Hematology Annual Meeting , European Hematology Association , Janssen Research Development , Congress Abstract , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Levine Cancer Institute , Clinical Research , American Cancer Society , None Of The Janssen Pharmaceutical Companies , Exchange Commission , Companies Of Johnson , European Medicines Agency Seeking Approval , European Medicines Agency ,